Professor Philip COTTON, Vice Chancellor of the University of Rwanda and Dr. Clet Niyikiza, Founder, President & CEO of L.E.A.F. Pharmaceuticals LLC signed a Memorandum of Understanding to promote and strengthen academic and research collaboration.
Prof Cotton shakes hands with Dr. Clet Niyikiza, Founder, President & CEO of L.E.A.F
Speaking on this occasion, Professor Philip Cotton said, “we are really pleased to enter into this academic collaboration with L.E.A.F which is highly reputed in in developing and commercializing innovative and safe therapies for cancer and other diseases. This MoU will benefit the university of Rwanda, especially by providing up to date learning and teaching environments for undergraduate and postgraduate students.” As the University Management, we shall do all that is possible to ensure that this collaboration succeeds,” he reassured.
Speaking on behalf of L.E.A.F, Dr. Clet Niyikiza, said that it was a great honour for his delegation to visit the University of Rwanda and sign the MoU. He shared that L.E.A.F’s strength in the field of Laboratory management and related research will help to take UR’s research to the next level.
L.E.A.F. Pharmaceuticals LLC, is a global pharmaceutical company located in the historic area of Valley Forge, Pennsylvania, USA, with a mission to discover, develop and commercialize innovative and safe therapies for cancer. Recently, L.E.A.F. Rwanda, in partnership with L.E.A.F. Pharmaceuticals, confirmed to start making available its first anticancer medicine in Africa starting in 2019.
Staff management of both sides witnessing the signing of MoU
Published by UR Communication Department